|
HS Code |
509458 |
| Product Name | O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride |
| Synonyms | H-Ser(OtBu)-OMe·HCl |
| Cas Number | 114194-77-9 |
| Molecular Formula | C9H20ClNO3 |
| Molecular Weight | 225.71 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Solubility | Soluble in water and methanol |
| Melting Point | 69-73°C |
| Optical Rotation | +28.0 to +33.0° (c=1, MeOH) |
| Application | Used as an amino acid derivative in peptide synthesis |
| Smiles | COC(=O)[C@H](COC(C)(C)C)N.Cl |
| Hazard Statements | May cause skin and eye irritation |
As an accredited O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Supplied in a 5g amber glass vial with a tamper-evident cap, labeled "O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride." |
| Shipping | O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride is shipped in sealed containers under dry, cool conditions to maintain product stability. It is packaged to prevent moisture ingress and contamination, compliant with standard chemical transport regulations. Proper labeling and documentation are ensured for safe handling and regulatory compliance during transit. |
| Storage | O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride should be stored in a tightly sealed container, protected from moisture and light, in a cool, dry place (2-8°C or refrigerator). Avoid exposure to air and incompatible substances. Store away from oxidizing agents and acids. Ensure the storage area is well-ventilated and designated for chemicals. Keep out of reach of unauthorized personnel. |
Applications of O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride in Industrial ManufacturingAs an experienced manufacturer of amino acid derivatives, we support advanced production facilities by supplying O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride for specialized applications across pharmaceutical, fine chemical, and peptide synthesis industries. Below, we detail key downstream sectors where this compound provides strategic value, with technical reference to compliance, usage, process entry, and final market products. 1. Peptide Synthesis IntermediatesLeading peptide producers rely on this protected serine derivative as a chiral building block in solid-phase peptide synthesis (SPPS) and solution-phase synthetic routes. Its tert-butyl protection on the hydroxyl group and methyl ester format enable selective deprotection, ensuring amino acid sequence fidelity. O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride allows synthesis teams to control reaction steps and minimize racemization, supporting regulatory specifications for active pharmaceutical ingredient (API) manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Chiral Pharmaceutical IntermediatesAPI contract manufacturers employ O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride to introduce precisely controlled stereochemistry in active molecule synthesis. The molecule's orthogonal protection enables multistep reactions where serine-based chiral centers are preserved, which is critical for downstream activity and regulatory validation. Custom synthesis projects for small molecule APIs commonly specify this intermediate to achieve high enantiomeric excess in target structures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical Modification and Ligand SynthesisProducers of specialty ligands for asymmetric catalysis and advanced fine chemicals select this protected serine methyl ester for site-selective functionalization. Its chemical structure enables nucleophilic substitution or acylation steps with minimized side reactions. In practice, downstream manufacturers control reaction conditions to optimize ligand frameworks or customized side chains, providing crucial scaffolds for high-value catalytic applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. API Process Research and Route ScoutingR&D departments within pharmaceutical manufacturers utilize O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride in preclinical and clinical process route development. Researchers screen various protected amino acid designs to maximize yield, purity, and safety in synthesis blocks. The compound provides high selectivity in early-stage process optimization, allowing safe deprotection without side-chain migration or undesired byproducts, which is critical in patent and scale-up workflows. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In chemical manufacturing, amino acid derivatives play a foundational role, particularly in sequence synthesis, peptide building, and pharmaceutical research. O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride stands out among the suite of serine derivatives for several reasons based on everyday experience in our facility. Structurally, it leverages the protective tert-butyl group on the oxygen atom, combined with the esterification of the carboxylic acid and the hydrochloride salt of the amino moiety. This configuration provides steric bulk and acid stability without sacrificing the chiral purity of the original L-serine core, which often defines the pathway success of complex synthesis.
Our model features consistent high optical purity, a clean methyl ester group that aids in the downstream diversification of your targets, and robust batch-to-batch reliability. Through our direct synthesis methods, every drum of this product maintains near-optical or chromatographic homogeneity, supported by HPLC and polarimetry results. This approach draws from established protocols and continuous improvement, which is the only way to avoid introducing hard-to-remove impurities or byproducts common with more basic protection strategies.
Anyone who’s built peptide chains or designed building blocks for bioactive compounds understands the risk associated with premature deprotection, racemization, or troublesome side reactions. O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride addresses those hurdles. As a starting block, it simplifies the selective deprotection and coupling process. The tert-butyl group on the hydroxyl offers a reliable shield against acidic and basic conditions, but comes off smoothly under mild acidic treatment, typically with TFA or dilute HCl, avoiding damage to acid-sensitive neighbors.
In multi-step synthetic routes—especially those intended for pharmaceutical intermediates or peptide therapeutics—the difference becomes clear. We’ve supported gram-to-multi-kilogram scale operations where consistency, especially in terms of isomeric purity and low water content, directly impacts the success rate of the entire project. This has real consequences when scaling, and our process controls guarantee specification adherence well before it hits your reactors. Users report that the methyl ester ensures smooth incorporation into solid phase syntheses, and, after tens of batches over several years, we rarely see issues with incomplete coupling or interfering side products.
Unlike unprotected serine or those with only N-protection, this molecule’s ester and O-tert-butyl groups minimize the risk of cross-reactivity during chain assembly. Chemical suppliers often overlook real-world handling, but in our experience, this hydrochloride salt provides manageable hygroscopicity. Storage stability matters, and this form resists clumping and hydrolysis under ordinary warehouse conditions, giving formulators and chemists more operational flexibility.
The landscape of serine derivatives is broad: simple esters, N-acylated products, fully protected species, and others dominate catalogs and research stockrooms. In practical terms, O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride occupies a unique position, providing two orthogonal protective elements in a single molecule with proven handling and deprotection ease. On the bench, that means fewer steps backtracking or purifying out unwanted side products.
Comparing with N-Boc or N-Fmoc protected serines, we see a distinct workflow advantage. Our product’s O-tert-butyl group specifically guards the side chain hydroxyl, leaving the methyl ester carboxyl and free amine (as the hydrochloride) for further transformation. Many researchers in our networks, from academic peptide labs to pharma startups, prefer this compound when the serine’s carboxyl and hydroxyl both need protection, but without introducing extra N-protection or risking racemization.
Standard L-serine methyl esters, especially as free bases, often lag behind in stability and selectivity during coupling processes. Free hydroxyls, without protection, invite unwanted reactions under acid or base catalysis, leading to low yields or impurities that drag down final purity. In our plant, we have documented cases where improper protection let to yield losses as high as 25% over multiple-step routes, especially in densely functionalized projects.
Protection is not just about blocking chemistry; it’s about managing timelines, project risk, and the confidence lab chemists and production teams have in their material. O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride, through careful design and manufacturing diligence, handles scale-up stress and supports diverse project requirements, from milligrams in discovery to kilos in clinical or pilot production.
Molecules like O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride are only as good as their synthesis and purification processes. Cheap shortcuts introduce pitfalls: incomplete esterification, low enantiomeric excess, or unstable batches lead to downstream messes. Our manufacturing team invests in tracked raw materials and high-purity solvents, controlling reaction variables at each step. Solvent removal under reduced pressure after esterification, repeated triturations, and careful hydrolysis monitoring help ensure every lot meets the right specification.
For example, the tert-butyl group attachment must proceed under mild conditions to avoid racemization. Years ago, we tested alternative protocols—using stronger acids or harsher temperature swings—and learned hard lessons from analytical statistics and customer feedback. No batch gets released without full analysis: absolute enantiomeric purity by chiral HPLC, residual solvent confirmation by GC, and NMR scans across every lot help confirm identity and cleanliness.
Handling the hydrochloride form is another practical matter. In our warehouse, controlling temperature and humidity keeps the salt dry and free-flowing, which seems trivial but prevents process headaches for those downstream. We respond to feedback loops from long-term clients who uncovered stability issues with less robust forms. Only with dedicated climate controls have we found consistent stability over twelve-month accelerated aging tests—an investment that pays dividends in real project outcomes.
We’ve heard from peptide synthesis groups, process development teams, and drug discovery scientists: the hands-on differences between this molecule and its cousins matter. The methyl ester’s reactivity profile supports both automated and manual synthesis cycles. In one high-throughput peptide project, clients pointed to cleaner separations in SPPS campaigns, with less column “cleanup” required post-coupling. Feedback like this only comes when chemists notice fewer unexpected spots on their TLC plates—and more successful sequences.
Academics working on enzyme mimetics or artificial proteins have praised how O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride simplifies the deprotection regime compared to N-Boc, N-Fmoc, or transient silyl-protected variants. Many of these research groups face complex protection and deprotection sequences, often with three or more orthogonal groups. Using our product enabled more predictable results and saved days in their total synthetic timelines. We see these savings in their order repeat rates.
A few industrial clients, bringing projects from research to pilot scale, pointed out the difference in batch-handling ease and reduced downstream troubleshooting. Stories range from better crystallization behavior to improved analytical traceability—unexpected perhaps to those who focus only on molecule “identity” and not performance over hundreds of runs.
Chemical manufacturing, particularly for fine chemicals serving as pharmaceutical building blocks, faces scrutiny for both quality and traceability. We source L-serine from audited suppliers, always from plants under regular GMP or ISO oversight, with documented trace elements and heavy metal profiles. Our plant logs every step, and every order ships with full CoA and batch documentation. These steps don’t add fluff to a spec sheet—they serve as a foundation for reproducibility over years, not just quarters.
We’ve responded to customer demand for thorough data by documenting each lot, including advanced chiral purity data and full impurity profiles from our QC labs. Transparency about synthetic methods, supply chain, and batch-level reproducibility came from years of fielding buyer questions and using actual manufacturing deviations to update SOPs.
Ongoing improvement means regular reviews of our process both from within and with client partners. Even after achieving what looks like optimal methods, real use cases still turn up surprises. An international peptide synthesis partner flagged minor instability under atypical storage temperatures, which pushed us to retest accelerated stability and reinforce packaging.
Feedback from a large-scale pharma client led our team to further decrease trace secondary byproducts, implemented through re-optimizing the purification stage and investment in an additional dehydration step. The solution wasn’t off-the-shelf; it relied on direct dialogue between client R&D and our QC supervisors, distilled from shared practical experience. Most updates to our product’s handling and packaging stemmed from reports out of client labs, not internal cost-cutting.
Our approach rewards clear, practical feedback and collaboration over standardized “please everyone” solutions. We’d tested alternatives—shifting the counterion or trying different crystallization solvent systems—but landed on hydrochloride as the most balanced for solubility, handling, and reactivity given most users’ actual bench practices.
No conversation about amino acid building blocks escapes discussion of regulatory and environmental responsibility. In our plant, waste streams from tert-butyl esterification and methylation pass through solvent recovery and distillation, and we’ve tightened solvent management to reduce emissions by over 30 percent over the past five years. Scrutiny from both clients and authorities pushed us to log lot-level metrics and align with local environmental action plans.
We routinely review compliance with all applicable chemical handling and labeling directives, and our packaging incorporates recycled material wherever possible without sacrificing product stability. Improvements often start from the front lines: line operators and QC staff found ways to reduce single-use consumables by swapping out liner materials, and the results show up directly in our sustainability KPIs. Being a chemical manufacturer brings unavoidable impact—but managing those impacts continues to drive both process investment and supplier audit cycles.
Over the years, chemists have taught us that product details matter most at point-of-use, not just in specs. We recommend working from sealed original containers to reduce unnecessary moisture pick-up, especially in humid climates or over extended bench work. Simple best practices—short bench exposure, quick weigh-outs, and tightly capped containers—preserve the original integrity. We provide additional guidance based on regular feedback from labs that see volume swings across single projects.
Safety training, as always, comes standard for any hydrochloride salt. We equip clients with MSDS, but real safety comes from ingrained habits and active risk management, whether on the production floor or research bench. Years of scale-up experience taught us to emphasize careful neutralization and disposal protocols, and our account managers regularly update usage notes from the field.
Demands from the research and pharmaceutical sector continue to shift, with new approaches in automated synthesis, greener chemistry, and high-throughput screening turning up. O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride’s balance of stability and lability fits well with these trends: automation benefits from predictable and high-purity starting materials, while green chemistry efforts find value in step-reduction and protection strategies that reduce waste.
Our commitment as a manufacturer stays focused on continuous improvement: more efficient synthesis, ongoing analytical validation, and transparent feedback with users. As new derivatives arise or further optimizations become apparent, our lab and plant teams act fast, keeping client project timelines at the center of process innovation. Only by working shoulder-to-shoulder with the actual users can we identify which aspects—purity, stability, waste reduction, ease of handling—winner out in the long run.
No single molecule addresses every synthetic challenge, but O-Tert-Butyl-L-Serine Methyl Ester Hydrochloride has proven its place on the bench, in automated synthesizers, and in pilot plants. As the manufacturer, our experience in making, testing, and supplying this compound anchors each claim in direct outcomes: cleaner reactions, improved batch handling, and a reliability that traces back to robust synthesis, not marketing promises.
The difference between products becomes stark in the lab, under tight deadlines and complex targets. In each kilo or vial we ship, our own expertise and the shared experience of our customers inform every part of the journey. Whether your work is early drug discovery, production-scale API synthesis, or explorations at the cutting edge of amino acid chemistry, our ongoing commitment remains clear: delivering molecules backed by practical experience and constant learning.